Immune Checkpoint Inhibitors +/− Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta‐Analysis

Immune Checkpoint Inhibitors +/− Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta‐Analysis

ABSTRACT Background Multiple studies have demonstrated the intracranial efficacy of immune checkpoint inhibitors (ICI) +/− chemotherapy. The efficacy of chemoimmunotherapy compared to ICI alone in patients with metastatic NSCLC and brain metastases (BM) remains unknown. Methods A systematic review a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lauren Julia Brown, Nicholas Yeo, Harriet Gee, Benjamin Y. Kong, Eric Hau, Inês Pires daSilva, Adnan Nagrial
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Thoracic Cancer
Subjects:	brain metastases chemoimmunotherapy immune checkpoint inhibitors network meta‐analysis non‐small cell lung cancer
Online Access:	https://doi.org/10.1111/1759-7714.15510
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study
by: Yuchen Wang, et al.
Published: (2025-01-01)

Lung Metastases to the Heart with Atypical Clinical Manifestations of Cardiac Failure
by: Natalia HYRIAVENKO, et al.
Published: (2023-03-01)

Omental metastases in patients with pseudomyxoma peritonei or colorectal peritoneal metastases – is routine omentectomy justified?
by: Malin Enblad, et al.
Published: (2024-12-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01)

Subacute parkinsonism induced by immune checkpoint inhibitors
by: Lénia Silva, et al.
Published: (2024-12-01)

Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01)

Outcomes of Pembrolizumab plus chemotherapy for patients with metastatic non-squamous NSCLC: Real-world evidence
by: Irina Surovtsova, et al.
Published: (2025-12-01)

Radiomics-based Machine Learning Approach to Predict Chemotherapy Responses in Colorectal Liver Metastases
by: Yuji Miyamoto, et al.
Published: (2025-01-01)

Perioperative or neo/adjuvant chemoimmunotherapy versus chemotherapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis
by: Qiong Zhang, et al.
Published: (2025-01-01)

Efficacy of first-line radiofrequency ablation combined with systemic chemotherapy plus targeted therapy for initially unresectable colorectal liver metastases
by: Yaqing Kong, et al.
Published: (2025-12-01)

The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC
by: Yifan Wang, et al.
Published: (2025-01-01)

Clinical Characteristics of Choroidal Metastases
by: Bożena Romanowska-Dixon, et al.
Published: (2024-10-01)

Liver metastases in gastroenteropancreatic neuroendocrine tumours – treatment methods
by: Paweł Gut
Published: (2020-01-01)

Multiple acute complications of transarterial chemoembolization of liver metastases
by: R. N. Abu Shamsia, et al.
Published: (2024-12-01)

Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
by: Kun-Peng Wu, et al.
Published: (2025-12-01)

Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)
by: Chee Khoon Lee, PhD, et al.
Published: (2025-02-01)

Role of spindle assembly checkpoint proteins in gametogenesis and embryogenesis
by: Renju Pun, et al.
Published: (2025-01-01)

Efficacy and safety of perioperative sintilimab plus platinum-based chemotherapy for potentially resectable stage IIIB non-small cell lung cancer (periSCOPE): an open-label, single-arm, phase II trialResearch in context
by: Xiangyang Yu, et al.
Published: (2025-01-01)

Genetic Variations Affect Chemotherapy Outcomes: A Role of the Spindle-assembly Checkpoint
by: Sinjini Sarkar, et al.
Published: (2024-04-01)

Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeutics
by: B.E. Nelson, et al.
Published: (2025-03-01)

Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
by: Nan Niu, et al.
Published: (2025-01-01)

Resistance mechanisms to immune checkpoint inhibitors: updated insights
by: Besan H. Alsaafeen, et al.
Published: (2025-01-01)

Multiple brain metastases from mucoepidermoid carcinoma of the parotid gland: case report and review of the literature
by: Yao Christian Hugues Dokponou, et al.
Published: (2025-01-01)

Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study
by: Ping Zhou, et al.
Published: (2024-12-01)

Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint inhibitors for the treatment of locally advanced gastric cancer: a real - world retrospective cohort study
by: Zhouwei Zhan, et al.
Published: (2025-02-01)

Zosteriform cutaneous metastases: A rare occurrence in ductal carcinoma breast after mastectomy
by: Roshany Sakthibalan, et al.
Published: (2024-01-01)

Automatic detection and multi-component segmentation of brain metastases in longitudinal MRI
by: Vincent Andrearczyk, et al.
Published: (2024-12-01)

Hepatic sinusoidal obstruction syndrome (SOS) associated with checkpoint inhibitor therapy
by: Marianna Litterio, et al.
Published: (2024-12-01)

Treatment of metastatic brain lesion
by: A. M. Zaytsev, et al.
Published: (2015-06-01)

Retrospective comparative survival analysis of ablation plus systemic therapy versus systemic therapy alone for breast cancer liver metastases, stratified by extrahepatic metastases status
by: Xuxiazi Zou, et al.
Published: (2025-02-01)

Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal
by: Xinya Li, et al.
Published: (2024-11-01)

Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled Trials
by: Andrea Messori, et al.
Published: (2025-01-01)

Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence
by: Yuta Yamanaka, et al.
Published: (2024-12-01)

Immune checkpoint inhibitor‐related type 1 diabetes incidence, risk, and survival association
by: Fumika Kamitani, et al.
Published: (2025-02-01)

Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
by: Jiayuan Le, et al.
Published: (2025-12-01)

PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
by: Stefania Angelicola, et al.
Published: (2025-01-01)

Case report: Diagnosis of impaired consciousness in a cancer patient using immune checkpoint inhibitors
by: Daniel Cathalifaud, et al.
Published: (2025-01-01)

Prognostic value of the lactate dehydrogenase to albumin ratio in advanced non-small cell lung cancer patients treated with the first-line PD-1 checkpoint inhibitors combined with chemotherapy
by: Meifeng Luo, et al.
Published: (2025-02-01)

Acral Lentiginous Melanoma Presenting with Amelanotic Metastasis
by: Alaka J Mohan, et al.
Published: (2025-01-01)

Modern treatment methods of patients with liver metastases of colorectal cancer
by: Ye. N. Grebenkin, et al.
Published: (2013-07-01)